Tuesday, October 1, 2024
HomeTagsRead Magazine

Read Magazine

Maplight Therapeutics Announces Initiation of Phase 1 Clinical Trial for Novel Therapy

MapLight Therapeutics announced it has initiated a Phase 1 clinical trial evaluating ML-007, a novel therapeutic developed to target circuits understood to be dysfunctional...

Medline and Aerapy Partner on UV Disinfection for Ambulances

Medline and Aerapy announced a partnership to help enhance ambulance decontamination practices. Medline will now be the exclusive medical distributor of DuoGuard, an air...

Nuvo Group Presents New Data Supporting Expanded Capability of INVU Platform

Nuvo Group, a leader in modern maternal-fetal health, today presented new clinical data for INVUTM, the only FDA-cleared, prescription-initiated, remote pregnancy monitoring and management...

FDA Sodium Reduction Efforts Underscored in USDA’s Transitional Nutrition Standards for School Meals

One of the U.S. Food and Drug Administration's top priorities is to improve the health of Americans through better nutrition. We are pleased to...

Hemab Therapeutics Announces First Drug Candidate: HMB-001

Hemab Therapeutics, a biotechnology company developing next-generation therapeutics for serious, underserved bleeding and thrombosis disorders, unveiled its lead candidate, HMB-001, a novel bispecific antibody...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics